FIELD: chemistry.
SUBSTANCE: invention represents enterosorbent in form of pill, which contains colloidal silicon dioxide, microcrystal cellulose, dextrose, sodium croscarmellose, pharmaceutical talc and magnesium stearate, and components in enterosorbent are in specified ratio in wt %.
EFFECT: increase of sorption capacity and considerable reduction of production process due to reduction of granulate drying operation.
2 cl
Title | Year | Author | Number |
---|---|---|---|
ENTEROSORBENT | 2015 |
|
RU2602699C2 |
ENTEROSORBENT | 2009 |
|
RU2445103C2 |
DIETARY SUPPLEMENT FOR PREVENTING ALCOHOLIC INTOXICATION AND RELIEVING ALCOHOL WITHDRAWAL SYNDROME | 2014 |
|
RU2555769C1 |
METHOD FOR REMOVING SALTS OF HEAVY METALS FROM THE BODY | 2021 |
|
RU2777203C1 |
PHARMACEUTICAL COMPOSITION, INCLUDING MEMANTINE AND CITICOLINE, AND ALSO A DOSAGE FORM BASED ON SPECIFIED PHARMACEUTICAL COMPOSITION, INCLUDING MEMANTINE AND CITICOLINE, METHOD OF ITS OBTAINING AND USE OF DOSAGE FORM BASED ON PHARMACEUTICAL CEUTIC COMPOSITION, INCLUDING MEMANTINE AND CITICOLINE | 2020 |
|
RU2810575C1 |
PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING MENTAL, BEHAVIOUR AND COGNITIVE DISORDERS | 2012 |
|
RU2488388C1 |
ENTEROSORBENT | 2005 |
|
RU2279278C2 |
METHOD FOR PREPARING SOLID, ORAL PHARMACEUTICAL FORMULATION | 2009 |
|
RU2493850C2 |
METHOD FOR PRODUCTION OF ANTIOXIDANT PREPARATION IN FORM OF TABLET | 2020 |
|
RU2749718C1 |
COMBINATION TABLETTED FORM AND METHOD FOR MANUFACTURING IT | 2011 |
|
RU2578482C2 |
Authors
Dates
2015-01-10—Published
2013-09-13—Filed